Nova Leap Health Corp.
NVLPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $17 | $14 | $16 | $35 |
| - Cash | $1 | $1 | $1 | $2 |
| + Debt | $3 | $1 | $4 | $6 |
| Enterprise Value | $18 | $15 | $18 | $39 |
| Revenue | $26 | $26 | $28 | $21 |
| % Growth | -1.6% | -7.2% | 32.5% | – |
| Gross Profit | $10 | $10 | $10 | $7 |
| % Margin | 38.4% | 37.3% | 35.4% | 33.9% |
| EBITDA | $1 | -$0 | $0 | $4 |
| % Margin | 4.4% | -1.3% | 1.3% | 17.6% |
| Net Income | $1 | -$1 | -$1 | $2 |
| % Margin | 5.4% | -4% | -3% | 8.3% |
| EPS Diluted | 0.016 | -0.012 | -0.01 | 0.023 |
| % Growth | 229.5% | -18.4% | -145.8% | – |
| Operating Cash Flow | $1 | $2 | $1 | $2 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | $1 | $2 | $1 | $2 |